BeneFIX
| Product Specs | Description |
|---|---|
| Manufacturer Name | Pfizer |
| Description | BeneFIX is an antihemophilic factor (recombinant) indicated in adults and children with hemophilia B. |
| Indications for Adults: | |
Control and Prevention of Bleeding Episodes | Yes |
Perioperative Management | Yes |
Routine Prophylaxis to Prevent or Reduce the Frequency of Bleeding Episodes | Yes |
| Indications for Children: | |
Control and Prevention of Bleeding Episodes | Yes |
Perioperative Management | Yes |
Routine Prophylaxis to Prevent or Reduce the Frequency of Bleeding Episodes | Yes |
| Contraindications Nutrient in Cell Culture | Do not use in patients who have manifested life-threatening, immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster protein. |
| Viral Safety Process | Chromatography, membrane nanofiltration |
| Product Half-Life | 18.8 ± 5.4 hours |
| Product Recovery Percentage Mean incremental recovery IR (IU/dL per IU/kg) | Adults: 0.8 ± 0.2 |
| Manufacturing Method | A purified protein produced by recombinant DNA technology |
| Storage Requirements/Shelf Life |
|
| Nominal Vial Size & Diluent Volume | 250, 500, 1000, 2000, or 3000 IU/ 5 mL |